Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
James Mock Joins Moderna as Chief Financial Officer
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced […]
Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy
Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine’s […]
Standigm Names Carl Foster Chief Business Officer to Expand Strategic Partnerships for AI Drug Discovery
Standigm Inc. (“Standigm”), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment […]
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader
Jemincare, a leading pharmaceutical company from China, announced today that it and its wholly owned subsidiary […]
Incredible Health Raises $80M Series B, Reaching $1.65 Billion Unicorn Status as the Leader in Healthcare Hiring
Incredible Health, the fastest-growing career marketplace for permanent healthcare workers, today announced it has secured $80 […]
Philadelphia-based Biotech Company AUM LifeTech Awarded $400,000 NCI/NIH Grant to Advance Their Lung Cancer Immunotherapy Program Using RNA-Targeting Gene Therapy with Checkpoint Inhibitors
AUM LifeTech, Inc., a Philadelphia-based preclinical stage biotechnology company, has received a Small Business Innovation Research […]
GSK Completes Acquisition of Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a […]
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic
Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies […]
Remedium Bio Announces Successful $2.3M Expanded Seed Raise
Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more